Crowdonomics
All companies
GuruMD logo

GuruMD

Operating

GuruMD Virtual Med, Inc

Healthcare · Austin, TX

Urgent Telemedicine Join Us to Heal Our Healthcare System Together

Post-money valuation ⓘ
$9.9M
As of Apr 2019 · from Reg CF Offering (2018) · pre-money + amount raised, not a traded price
Total raised
$70,887
Across 1 round since 2018
Latest share price
$0.18
Reg CF Offering (2018) offering price

Financials

FY2016–FY2018 · from SEC filings · hover any figure for its source
$0
2016
$6K
−$124K
2017
$54K
−$187K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 reviewed*
FY2017 unaudited
FY2018 unaudited
Income statement
Revenue
$0
$6,384
$54,219
Cost of goods sold
$0
$126,738
$179,783
Gross margin
—
-1885%
-232%
Net income
$0
-$123,545
-$186,933
Taxes paid
$0
$0
$0
Balance sheet
Cash
$0
$6,203
$17,088
Accounts receivable
$0
$0
$0
Total assets
$0
$8,787
$46,282
Short-term debt
$0
$132,332
$309,754
Long-term debt
$0
$0
$0
Total liabilities
$0
$132,332
$309,754
Other
Headcount
—
6
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$9.8M
pre-money
Reg CF · Token · Oct 2018

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Share counts as of Dec 31, 2018
Class A Common Stock · 99.6%Common Stock · 0.44%
ClassOutstandingVotes / shareShare of totalLast price
Class A Common Stock54,500,000—99.6%—
Common Stock240,982—0.44%—
Total54,740,982100%

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Token · Oct 2018Closedvia StartEngine
Raised $70.9K / $1.1MInvestors 83Post-money $9.9M

Team

6 people
Clinton Osborn, MD.Founder
Co-Founder/ President of GuruMD

Dr. Osborn is CEO, co-founder and president of GuruMD. As a Board-Certified Physician, he's practiced medicine throughout The United States, working in Emergency Rooms, Hospital Systems, and Clinics treating acutely ill patients, Dr. Osborn felt it was time for a change, fueling the creation of the GuruMD platform. His passion for Med-Tech/ Fin-Tech, including cryptocurrencies, are combined to address many inefficiencies in medicine, sparking the idea and creation of GuruMD. He currently participates in various community outreach programs, is an active member of the Texas Medical Association, American Telemedicine Association, and advocate for increased accessibility for patient medical care. Dr. Osborn completed his family medicine residency in 2010 from Texas Tech University Health Science Center of the Permian Basin. From Nov. 2015-Sept. 2017, Dr. Osborn has worked full time as an Emergency Medicine Physician at EmCare. In Sept. 2017, he founded GuruMD, and still serves as CEO and Director. Dr. Osborn dedicates 10% of his time as a practicing Physician and the other 90% to GuruMD.

Kassey Osborn, FNP-CFounder
Co-Founder, COO, and Director of GuruMD

Kassey, co-found GuruMD in 2017, is an active Board-Certified Nurse Practitioner and Virtual medicine advocate. She helped lead, launch, and develop a disruptive Telemedicine platform straight out of the Silicon Hills of Austin, Texas. Kassey has traveled throughout the Lone Star State working in busy Emergency Rooms, Hospital Systems and Clinics. She is currently in charge of an active multi-state Virtual Medicine Pilot, www.gurumd.net, where she diagnoses, treats, and facilitates patient care, while leading the adaptation of the Platform. She led the development of the GuruPay™ system, designed to provide multiple payment options for the B2B sector as well as B2C. From 2015 - 2017, Kassey worked as a Nurse Practitioner in a busy Emergency Room and at a primary care clinic called Temple Walk-In Clinic. In Sept 2017, she co-founded GuruMD and works for the company full time as COO, CFO and Director.

Clinton Osborn
CEO, Principal Executive Officer and Manager, Principal Financial Officer and Principal Accounting Officer
Bradley Westmoreland
Public Relations Specialist

Bradley graduated from Texas State University and is the Senior Manager, State Government Affairs at Genentech.

J. Trevor Babyak
Business Strategy and Secretary

Trevor has served as GuruMD's Business Strategist and Secretary since 08/2018 . He founded CEO Symposium, in 12/2016. Prior thereto, between 01/2011 and 10/2016 he served as Program Administrator of the Bank CEO Network/ Bank Advisory Group where he was a financial analyst, providing bank stock valuations for community banks. Trevor graduated from Texas State University. Trevor devotes 90% of his time to GuruMD and 10% to CEO Symposium.

Wade Flasowski
Legal Counsel

Wade graduated from Texas Tech University and is a Litigation attorney at Fairchild Law Firm.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 8 annual reports (FY2018–FY2025)

83 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TRJun 5, 20200001665160-20-000728
    EDGAR
  • Form C-ARMay 1, 20190001755891-19-000001
    EDGAR
  • Form C-UMay 1, 20190001665160-19-000593
    EDGAR
  • Form C/AMar 15, 20190001665160-19-000266
    EDGAR
  • Form C/AJan 14, 20190001665160-19-000065
    EDGAR
  • Form COct 19, 20180001665160-18-001117
    EDGAR
Source: ManualCIK 0001755891DEShare price $0.18

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.